Condition
Joint Hypermobility Syndrome
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed3
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06830655Not ApplicableEnrolling By Invitation
Functional and Performance Determinants in Climbers: Examining the Role of Mobility, Stability, and Fatigue Across Proficiency Levels
NCT07121179CompletedPrimary
Sleep Characteristics in Infants With Joint Hypermobility
NCT05633225CompletedPrimary
Central Sensitization and Physical Activity in Adolescents With HSD/hEDS
NCT04279990Completed
Assessment of Gastric Motility on Funtional Dyspepsia and Joint Hypermobility Syndrome
Showing all 4 trials